VELIZY-VILLACOUBLAY, France, July 27, 2026 – Dassault Systèmes is acquiring ArisGlobal, whose AI-native compliance platform processes more than 12 million patient safety reports annually for over 200 biopharma and medtech customers. The deal pushes Dassault Systèmes into regulated life sciences operations, adding clinical-grade AI and evidence management to its portfolio.
Half of the Top 50 global biopharma companies use ArisGlobal’s platform, alongside biotech firms, medtech companies, research organizations, and global health authorities. The company employs more than 1,300 people globally and expects to generate $175 million in revenue in 2026.
ArisGlobal’s NavaX AI platform runs clinical-grade AI at production scale within regulated environments. It is used across patient safety event tracking, medical affairs management, regulatory submissions, and quality processes. The platform delivers more than 30% productivity gains, according to the company.
The compliance software market is projected to grow at double-digit rates to reach $7.5 billion by 2030, with software and AI taking a share of that spend.
The acquisition extends Dassault Systèmes’ existing footprint in drug discovery, clinical trials, manufacturing, and quality.
Pascal Daloz, Dassault Systèmes’ chief executive officer and chairman of the board, commented: “Today marks a major milestone in our ambition to transform the Life Sciences industry by connecting molecule, patient and real-world outcomes. Life Sciences is entering a new era of innovation – driven by artificial intelligence and the shift to precision medicine – while facing increasing operational complexity and regulatory scrutiny. Our vision to virtualize the industry has never been more relevant. By bringing together real-world evidence with our unique modeling and simulation expertise, this unified data and intelligence platform radically improves our ability to address persistent drug development challenges, allowing our customers to deliver safer, innovative therapies at a faster pace. We are excited to welcome ArisGlobal’s exceptional leadership team and talented people to the Dassault Systèmes family.”
Aman Wasan, chief executive officer of ArisGlobal, added: “Life Sciences is approaching a fundamental inflection point. The future of Life Sciences will not be built on better software – it will be built on connected intelligence. For decades, Life Sciences organizations have operated across fragmented systems and disconnected data environments spanning research, development and regulated operations. By joining Dassault Systèmes, we are taking a major step forward in our vision to offer Life Sciences customers an integrated and comprehensive AI-first intelligence platform unifying fragmented datasets and ultimately delivering better health outcomes for patients at an accelerated pace. Dassault Systèmes is a science-based AI leader focused on transforming the Life Sciences industry globally. Its virtual twin, modeling and simulation capabilities, combined with ArisGlobal’s technology platform and AI capabilities, as part of NavaX and XDI, create a strong foundation that is unmatched. Together, we will help customers accelerate innovation, simplify complexity and continuously learn from every stage of the therapy lifecycle – ultimately delivering better outcomes for patients. I am personally thrilled to be joining the Dassault Systèmes organization and I look forward to executing on this ambitious vision.”
Source: Dassault Systèmes
About Dassault Systèmes
Dassault Systèmes SE, founded in 1981 and headquartered in Vélizy-Villacoublay, France, is a global software company focused on 3D design, digital mock-ups, and product lifecycle management. The company develops virtual tools that enable real-world applications across industries such as healthcare, manufacturing, and consumer products. Its software portfolio includes CATIA for product design, SOLIDWORKS for mechanical engineering, DELMIA for manufacturing workflows, and SIMULIA for advanced simulation. These solutions are used in aerospace, automotive, industrial equipment, consumer goods, life sciences, and technology sectors. Dassault Systèmes employed approximately 24,000 people across 200 offices worldwide.
About ArisGlobal
ArisGlobal develops software for drug safety, regulatory submissions, quality management and medical affairs. Its LifeSphere system manages safety cases, documents, product data and compliance records. The company also provides software for reviewing data and processing regulated tasks. Its services include implementation, data migration, system integration and business consulting. ArisGlobal serves pharmaceutical companies, biotechnology firms, medical device manufacturers, research contractors and health authorities. Customers use its software during drug development, post-market monitoring, reporting and quality management. Deepak Abbhi founded the company in 1987. ArisGlobal is headquartered in Waltham, MA, and maintains offices across Europe and Asia. The company serves more than 200 customers worldwide and employs more than 1,300 people.